The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Side Effects of Methylphenidate and Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial
Abstract
Objective. To compare the side effect profiles of methylphenidate (MPH) and dexamphetamine (DEX) in children with attention deficit hyperactivity disorder (ADHD), as well as to determine which symptoms are genuine adverse effects of stimulant medication, as opposed to aspects of the child's underlying behavioral phenotype. Design. Double-blind, crossover study. Setting. Pediatric teaching hospital ambulatory behavior clinic. Subjects. A total of 125 children with ADHD with a mean age of 104.8 months. Interventions. Subjects received DEX (0.15 mg/kg/dose) and MPH (0.3 mg/kg/dose) twice a day for 2 weeks each in a randomized order. Outcome Measures. The Barkley Side Effects Rating Scale (17 symptoms; 0 = absent, severity rated from 1 to 9) was completed by parents at baseline and at the completion of each trial fortnight. Results. Subjects' parents reported a significantly greater mean number (8.19) and mean severity (4.08) of “side effects” before commencing the trial than during the MPH period (number 7.19; severity 3.24), but not the DEX period (number 7.64, severity 3.73). The mean severity (but not mean number) was greater on DEX than on MPH. DEX caused more severe insomnia and appetite suppression compared with the baseline rating. Appetite suppression was the only item rated more severe on MPH than at baseline. Six side effects were significantly more severe on DEX than MPH: insomnia, irritability, proneness to crying, anxiousness, sadness/unhappiness, and nightmares. None were more severe on MPH than DEX. Overall, both MPH and DEX were well tolerated by most subjects, with only four subjects discontinuing the trial period because of severe adverse effects (2 [1.6%] on each stimulant). Conclusions. Many symptoms commonly attributed to stimulant medication are actually preexisting characteristics of children with ADHD and improve with stimulant treatment. At the doses investigated, both DEX and MPH caused appetite suppression, and DEX caused insomnia. Negative emotional symptoms were more severe on DEX than MPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normative data on Revised Conners Parent and Teacher Rating Scales
Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978) · Journal of Abnormal Child Psychology · doi:10.1007/bf00919127 · Cited by 1,720
THE BEHAVIOR OF CHILDREN RECEIVING BENZEDRINE
Bradley, C. (1937) · American Journal of Psychiatry · doi:10.1176/ajp.94.3.577 · Cited by 1,035
A REVIEW OF STIMULANT DRUG RESEARCH WITH HYPERACTIVE CHILDREN
Barkley, R. A. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00425.x · Cited by 541
Barkley, R. A., McMurray, M. B., EDELBROCK, C. S., & Robbins, K. (1990) · PubMed · Cited by 433
Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys
Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978) · Science · doi:10.1126/science.341313 · Cited by 373
Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990) · Pediatrics · doi:10.1542/peds.86.2.184 · Cited by 372
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · Pediatrics · doi:10.1542/peds.86.2.226 · Cited by 249
Placebo-Controlled Evaluation of Ritalin Side Effects
Ahmann, P. A., Waltonen, S. J., Theye, F. W., Olson, K. A., & Van Erem, A. J. (1993) · Pediatrics · doi:10.1542/peds.91.6.1101 · Cited by 178
The computerized continuous performance task: A new measure of inattention
Klee, S. H., & Garfinkel, B. D. (1983) · Journal of Abnormal Child Psychology · doi:10.1007/bf00917077 · Cited by 177
Ck, C. (1972) · PubMed · Cited by 93
Millichap, J. G., & Fowler, G. W. (1967) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)32054-5 · Cited by 92
SYMPOSIUM: BEHAVIOR MODIFICATION BY DRUGS
Conners, C. K. (1972) · PEDIATRICS · doi:10.1542/peds.49.5.702 · Cited by 83
Dextroamphetamine and Methylphenidate in the Treatment of Hyperactive/Aggressive Children
Winsberg, B. G., Press, M., Bialer, I., & Kupietz, S. S. (1974) · PEDIATRICS · doi:10.1542/peds.53.2.236 · Cited by 65
Recent Drug Studies With Hyperkinetic Children
Conners, C. K. (1971) · Journal of Learning Disabilities · doi:10.1177/002221947100400904 · Cited by 62
Psychological Effects of Stimulant Drugs in Children with Minimal Brain Dysfunction.
Conners, C. K. (1972) · PEDIATRICS · Cited by 61
Cited by
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
Weiss, M. D., Wasdell, M. B., Bomben, M. M., Rea, K., & Fréeman, R. D. (2006) · PubMed · doi:10.1097/01chi.0000205706.78818.ef · Cited by 1,216
Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 878
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Fishman (2006) · doi:10.1097/01 · Cited by 547
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S. J., Gifford, A. N., Ding, Y., et al. (2002) · Synapse · doi:10.1002/syn.10075 · Cited by 452
Metadata
- Authors
- Efron, D., Jarman, F., & Barker, M.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1997-10-01
- Volume
- 100
- Issue
- 4
- Pages
- 662-666
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W1993767643
- Cited by
- 303
- References
- 16
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.